This website is for UK healthcare professionals only and contains promotional content.

Report an adverse event here

NOTICE: Kyowa Kirin International has agreed a joint venture with Grünenthal GmbH for the Established Medicines portfolio. The new company, KKI NewCo (known as Grünenthal Meds), is responsible for the content on this page. For more information please click here.

Opioid-induced Constipation

Opioid-induced Constipation (OIC) is a common, yet frequently under-recognised and poorly managed complication of opioid therapy.1

Average:

  • References

    1. Farmer A, Drewes A, Chiarioni G, et al. Pathophysiology and management of opioid-induced constipation: European expert consensus statement. United European Gastroenterology Journal. 2019;7(1):7–20.

    KKI/INT/KKI/0598 November 2023